Cord Blood Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningFetal BloodHematologic NeoplasmsTransplantation, AutologousStem CellsUmbilical CordPeripheral Blood Stem Cell TransplantationHistocompatibility TestingCytomegalovirus InfectionsTransplantation ChimeraTreatment OutcomeBone Marrow TransplantationRoseolovirus InfectionsTissue DonorsHematopoietic Stem CellsGraft vs Leukemia EffectMyeloablative AgonistsBusulfanRecurrenceVidarabineGraft SurvivalAspergillosisRetrospective StudiesRemission InductionCytomegalovirusGraft vs Tumor EffectLeukemiaImmunosuppressive AgentsAntigens, CD34Leukemia, Myeloid, AcuteMultiple MyelomaWhole-Body IrradiationHistocompatibilitySiblingsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte TransfusionCombined Modality TherapySalvage TherapyLymphocyte DepletionTime FactorsSurvival AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaMinor Histocompatibility AntigensSurvival RateVirus ActivationDisease-Free SurvivalAntilymphocyte SerumT-LymphocytesMyelodysplastic SyndromesChimerismHematopoietic Stem Cell MobilizationBlood BanksNeoplasm, ResidualAnemia, AplasticHematologic DiseasesEmbryonic Stem CellsHepatic Veno-Occlusive DiseaseImmunocompromised HostHLA AntigensCell DifferentiationMesenchymal Stem Cell TransplantationMelphalanAcute DiseaseCells, CulturedSpinal CordCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsAdult Stem CellsFlow CytometryFollow-Up StudiesMesenchymal Stromal CellsImmunosuppressionInfant, NewbornKidney TransplantationOpportunistic InfectionsBone Marrow CellsCell TransplantationTransplantationTransplantation ImmunologyPrognosisGraft RejectionPrimary MyelofibrosisCell SeparationLymphoproliferative DisordersLiver TransplantationImmunophenotypingAntigens, CDGanciclovirLeukemia, MyeloidMycosesAntineoplastic AgentsLeukemia, Myeloid, Accelerated PhaseFatal OutcomePluripotent Stem CellsGranulocyte Colony-Stimulating Factor